Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BEKE-W
02423
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 61.78%-4.47M | -468.90%-5.62M | -3,550.00%-4.9M | 154.45%7.18M | 639.43%21.08M | -2,268.65%-11.69M | 347.00%1.52M | 101.52%142K | 61.89%-13.19M | -152.95%-3.91M |
| Net income from continuing operations | -74.43%-10.41M | -221.88%-5.05M | 82.04%-2.45M | 56.07%-21.84M | 71.33%-4M | 50.00%-5.97M | 131.39%4.15M | -28.42%-13.65M | -52.07%-49.72M | 17.47%-13.95M |
| Operating gains losses | 172.28%4.48M | 95.63%-538K | 86.86%3.34M | -179.63%-2.57M | 676.85%6.16M | 67.52%1.65M | -625.18%-12.31M | 88.91%1.79M | 123.70%3.23M | -323.22%-1.07M |
| Depreciation and amortization | -23.56%172K | 29.59%219K | -40.56%1.93M | -30.66%8.66M | 104.01%6.57M | -93.08%225K | -94.35%169K | 7.27%3.25M | 5.85%12.49M | 16.67%3.22M |
| Asset impairment expenditure | --0 | -54.40%140K | -34.93%190K | -52.69%3.57M | -45.12%2.62M | -45.52%438K | -76.02%307K | -56.42%292K | 391.84%7.54M | 1,987.77%4.78M |
| Remuneration paid in stock | 113.44%397K | -43.24%126K | -35.95%212K | -38.27%1.07M | -38.22%409K | 160.00%186K | -70.08%222K | -47.71%331K | -16.41%1.73M | 604.26%662K |
| Deferred tax | 12.50%9K | -166.67%-6K | 17.50%-33K | 329.21%1.8M | 504.81%1.77M | 102.47%8K | -92.80%9K | 72.97%-40K | -78.18%-784K | 0.68%-437K |
| Other non cashItems | 15.79%22K | 91.67%23K | 109.73%22K | -97.46%74K | 104.88%21K | -88.55%19K | -99.60%12K | -315.24%-226K | 616.46%2.92M | 86.81%-430K |
| Change In working capital | 110.48%864K | -105.95%-533K | -196.61%-8.11M | 74.56%16.43M | 127.62%7.53M | -204.22%-8.24M | 320.65%8.96M | 313.39%8.4M | 448.11%9.41M | -86.45%3.31M |
| -Change in receivables | 895.56%2.33M | -1,248.76%-8.16M | -116.54%-2.07M | 378.78%25.57M | 203.03%9.2M | -110.18%-293K | -229.00%-605K | 1,303.27%12.53M | 449.48%5.34M | 141.34%3.04M |
| -Change in inventory | 127.33%1.44M | 3.52%5.88M | -0.91%-7.5M | -172.10%-6.84M | -203.86%-7.53M | -256.50%-5.26M | 1,157.54%5.68M | -1,157.87%-7.43M | 370.50%9.48M | -17.28%7.25M |
| -Change in prepaid assets | -112.12%-304K | 238.98%600K | -3.75%-415K | -105.33%-153K | -560.19%-2.82M | 32.82%2.51M | -94.27%177K | 76.25%-400K | 2,241.04%2.87M | -111.83%-427K |
| -Change in payables and accrued expense | 50.20%-2.67M | -75.15%1.06M | -39.89%2.84M | 191.22%2.23M | 379.32%12.13M | -735.43%-5.36M | 1,380.84%4.25M | 519.27%4.73M | -2,106.56%-2.45M | -141.86%-4.34M |
| -Change in other current liabilities | -56.17%71K | 117.13%92K | 5.59%-963K | 24.86%-4.38M | -56.05%-3.44M | 115.27%162K | 54.45%-537K | 26.19%-1.02M | -349.00%-5.83M | -124.49%-2.21M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 61.78%-4.47M | -468.90%-5.62M | -3,550.00%-4.9M | 154.45%7.18M | 639.43%21.08M | -2,268.65%-11.69M | 347.00%1.52M | 101.52%142K | 61.89%-13.19M | -152.95%-3.91M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 54.81%14.52M | -164.81%-5.01M | 156.83%2.7M | 128.98%4.47M | -234.42%-11.88M | 329.87%9.38M | 258.64%7.73M | -63.56%-4.76M | -187.34%-15.41M | 35.14%-3.55M |
| Net PPE purchase and sale | -180.87%-514K | 34.87%-822K | 35.79%-3.14M | -8.66%-16.92M | -311.45%-14.73M | 95.52%-183K | 74.27%-1.26M | -62.72%-4.89M | -9.35%-15.57M | 38.17%-3.58M |
| Net business purchase and sale | --15.04M | 57.73%-4.19M | ---4.69M | ---9.9M | --0 | --0 | ---9.9M | --0 | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | ---- | --29.99M | --1.56M | --9.56M | --18.89M | ---- | --0 | --0 |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --297K | --0 | --0 | --297K | ---- | --0 | --0 |
| Net other investing changes | ---- | ---- | 7,701.48%10.53M | 519.88%998K | 1,296.43%391K | --38K | 1,140.00%434K | 37.76%135K | -77.98%161K | --28K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 54.81%14.52M | -164.81%-5.01M | 156.83%2.7M | 128.98%4.47M | -234.42%-11.88M | 329.87%9.38M | 258.64%7.73M | -63.56%-4.76M | -187.34%-15.41M | 35.14%-3.55M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 77.41%-993K | 83.86%-1M | 32.92%-3.92M | -1,033.54%-25.21M | -138.64%-7.32M | -12.69%-4.4M | 56.99%-6.2M | -112.94%-5.84M | 88.55%-2.22M | 2,907.46%18.95M |
| Net issuance payments of debt | 77.41%-993K | 83.86%-1M | 32.92%-3.92M | -490.07%-25.21M | -138.64%-7.32M | -12.69%-4.4M | -8.34%-6.2M | -112.94%-5.84M | 145.44%6.46M | 2,907.46%18.95M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -67.06%-8.69M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 77.41%-993K | 83.86%-1M | 32.92%-3.92M | -1,033.54%-25.21M | -138.64%-7.32M | -12.69%-4.4M | 56.99%-6.2M | -112.94%-5.84M | 88.55%-2.22M | 2,907.46%18.95M |
| Net cash flow | ||||||||||
| Beginning cash position | -48.50%21.38M | -25.66%32.64M | -31.37%37.65M | -36.35%54.85M | -24.36%33.26M | -20.55%41.52M | -38.99%43.9M | -36.35%54.85M | -30.99%86.18M | -49.17%43.97M |
| Current changes in cash | 246.52%13.82M | -904.88%-15.85M | 41.54%-6.11M | 56.02%-13.56M | -31.14%7.91M | -26.78%-9.44M | 92.07%-1.58M | 30.20%-10.46M | 15.28%-30.83M | 353.63%11.49M |
| Effect of exchange rate changes | -280.43%-2.11M | 671.98%4.59M | 323.48%1.1M | -627.94%-3.65M | -486.67%-3.52M | 236.68%1.17M | -511.79%-803K | -165.00%-494K | 78.38%-501K | 78.94%-600K |
| Cash adjustments other than cash changes | ---- | 45.38%-15.32M | ---- | ---- | ---- | ---- | ---28.05M | ---- | ---- | ---- |
| End cash Position | -0.48%33.1M | -54.99%6.06M | -25.66%32.64M | -31.37%37.65M | -31.37%37.65M | -24.36%33.26M | -74.22%13.47M | -38.99%43.9M | -36.35%54.85M | -36.35%54.85M |
| Free cash from | 58.04%-4.98M | -2,559.54%-6.44M | -69.25%-8.04M | 66.15%-9.74M | 184.75%6.35M | -235.18%-11.87M | 104.74%262K | 61.49%-4.75M | 41.46%-28.77M | -547.10%-7.49M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.